Get the Stockscreener App
22.57
0.18%
-0.04
Vera Therapeutics Inc stock is traded at $22.57, with a volume of 2.03M.
It is down -0.18% in the last 24 hours and up +1.26% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$22.61
Open:
$22.82
24h Volume:
2.03M
Relative Volume:
1.18
Market Cap:
$1.44B
Revenue:
-
Net Income/Loss:
$-107.85M
P/E Ratio:
-10.21
EPS:
-2.21
Net Cash Flow:
$-106.82M
1W Performance:
+4.78%
1M Performance:
+1.26%
6M Performance:
-21.03%
1Y Performance:
-42.31%
1-Day Range:
$22.41
$23.81
1-Week Range:
$21.20
$23.81
52-Week Range:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
22.57 | 1.39B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-05-25 | Resumed | H.C. Wainwright | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Jan-28-25 | Initiated | Goldman | Buy |
| Nov-21-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Strategies to average down on Vera Therapeutics Inc.2025 Market Outlook & Proven Capital Preservation Tips - Newser
Long term hold vs stop loss in Vera Therapeutics Inc.2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser
What data driven models say about Vera Therapeutics Inc.’s futureJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Vera Therapeutics Inc. stock prediction for this weekTrade Risk Report & AI Enhanced Trade Execution Alerts - Newser
Intraday pattern recognizer results for Vera Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Reversal indicators forming on Vera Therapeutics Inc. stockJuly 2025 Levels & Proven Capital Preservation Tips - Newser
Chart based analysis of Vera Therapeutics Inc. trendsJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Can momentum traders help lift Vera Therapeutics Inc.July 2025 Big Picture & Trade Opportunity Analysis - Newser
What institutional flow reveals about Vera Therapeutics Inc.Rate Hike & Precise Swing Trade Entry Alerts - Newser
Using flow based indicators on Vera Therapeutics Inc.Weekly Stock Recap & Growth Focused Entry Point Reports - Newser
When is the best time to exit Vera Therapeutics Inc.Earnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Can Vera Therapeutics’ (VERA) Widening Losses Challenge Its Path to Sustainable Growth? - Yahoo Finance
Pattern recognition hints at Vera Therapeutics Inc. upsideJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How sentiment analysis helps forecast Vera Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - Newser
Is This a Bottoming Phase for Vera Therapeutics Inc.July 2025 Outlook & AI Driven Stock Movement Reports - metrotimes.co.kr
Measuring Vera Therapeutics Inc.’s beta against major indices2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Can Vera Therapeutics Inc. stock recover from recent declineMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionMarket Sentiment Review & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-17 09:44:14 - metal.it
Will a bounce in Vera Therapeutics Inc. offer an exitQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy Trends2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
What’s next for Vera Therapeutics Inc. stock price2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Should I average down on Vera Therapeutics Inc. stockMarket Sentiment Report & Stock Market Timing Techniques - newsyoung.net
Vera Therapeutics Inc. Stock Performance After Earnings: Historical InsightsGold Moves & Free Safe Entry Trade Signal Reports - Newser
Vera Therapeutics shares fall 2.84% premarket after announcing inducement grants to new employees. - AInvest
Is Vera Therapeutics Inc. stock a hidden gemSmart Portfolio Allocation - thegnnews.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 - MarketScreener
10,496 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by XTX Topco Ltd - Defense World
Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
What makes Vera Therapeutics Inc. stock price move sharplyFree Portfolio Health Check - thegnnews.com
How to recover losses in Vera Therapeutics Inc. stockFree Investment Plan With Growth Optimization - Newser
JPMorgan Chase & Co. Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $53.00 - Defense World
Custom watchlist performance reports with Vera Therapeutics Inc.Portfolio Safety Metrics and Return Analysis - Newser
Vera Therapeutics: Equity Incentives and BLA Timelines Signal Confidence in Value Creation - AInvest
HC Wainwright Analysts Lower Earnings Estimates for VERA - Defense World
Lifesci Capital Has Negative Estimate for VERA Q3 Earnings - Defense World
Cantor Fitzgerald Issues Negative Forecast for VERA Earnings - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
Vera Therapeutics Inc. stock daily chart insightsTrade Ideas Based on Fundamental Metrics - Newser
Vera Therapeutics Awards Major Stock Package: 99,000 Options, 48,200 RSUs to Expand Team - Stock Titan
Wedbush Research Analysts Reduce Earnings Estimates for VERA - Defense World
Vera Therapeutics (VERA) to Release Quarterly Earnings on Thursday - Defense World
Can volume confirm reversal in Vera Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Vera Therapeutics Advances Clinical Trials and Financials Amid Progress Toward Commercial Launch - AInvest
Vera Therapeutics Q2 Net Loss Doubles, Revenue at $76.5 Million - AInvest
Vera (VERA) Q2 Net Loss Widens 127% - The Motley Fool
Vera Therapeutics Reports Progress in Clinical Trials - TipRanks
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $85 - 富途牛牛
Bkv Corporation shares rise 1.82% after-hours following Vera Therapeutics' positive trial results and upcoming BLA submission. - AInvest
Vera Therapeutics Signs New Sales Agreement with TD Securities - TipRanks
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vera Therapeutics Inc Stock (VERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):